Evidence map›Paper›PMID 31402090›Full record

ArticleAmerican journal of human genetics2019

De Novo Missense Variants in FBXW11 Cause Diverse Developmental Phenotypes Including Brain, Eye, and Digit Anomalies.

Richard J Holt, Rodrigo M Young, Berta Crespo, Fabiola Ceroni, Cynthia J Curry, Emanuele Bellacchio, Dorine A Bax, Andrea Ciolfi, Marleen Simon, Christina R Fagerberg and 24 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The RaDiCo information system for rare disease cohorts.Orphanet journal of rare diseases · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 18 institutions in 8 countries.

Richard J HoltFaculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, UK.
Rodrigo M YoungDepartment of Cell and Developmental Biology, Biosciences, University College London, Gower St, London WC1E 6BT, UK; Institute of Ophthalmology, University College London, 11-34 Bath Street, London EC1V 9EL, UK.
Berta CrespoGreat Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Fabiola CeroniFaculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, UK.
Cynthia J CurryGenetic Medicine, University of California, San Francisco/Fresno, Fresno, CA 93701, USA.
Emanuele BellacchioGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, Scientific Institute for Research, Hospitalization, and Healthcare, 00146 Rome, Italy.
Dorine A BaxFaculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, UK.
Andrea CiolfiGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, Scientific Institute for Research, Hospitalization, and Healthcare, 00146 Rome, Italy.
Marleen SimonDepartment of Genetics, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands.
Christina R FagerbergDepartment of Clinical Genetics, Odense University Hospital, 5000 Odense C, Denmark.
Ellen van BinsbergenDepartment of Genetics, University Medical Center Utrecht, 3508 GA Utrecht, the Netherlands.
Alessandro De LucaMolecular Genetics Unit, Fondazione Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.
Luigi MemoUnità Operativa Complessa di Pediatria e Patologia Neonatale, Ospedale San Martino, 32100 Belluno, Italy.
William B DobynsUniversity of Washington, Seattle, WA 98195-6320, USA; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle WA 98101, USA.
Alaa Afif MohammedWest Midlands Regional Genetics Laboratory, Birmingham Women's and Children's National Health Service Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2TG, UK; Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, 11562 Cairo, Egypt.
Samuel J H ClokieWest Midlands Regional Genetics Laboratory, Birmingham Women's and Children's National Health Service Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2TG, UK.
Celia Zazo SecoUDEAR, Université de Toulouse, UMRS 1056 Institut National de la Santé et de la Recherche Médicale-Université Paul Sabatier, 31059 Toulouse, France.
Yong-Hui JiangDepartment of Pediatrics and Neurobiology, Program in Genetics and Genomics, Duke University School of Medicine, Durham, NC 27710, USA.
Kristina P SørensenDepartment of Clinical Genetics, Odense University Hospital, 5000 Odense C, Denmark.
Helle AndersenHans Christian Andersen Children's Hospital, Odense University Hospital, 5000 Odense C, Odense, Denmark.
Jennifer SullivanDepartment of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC 27710, USA.
Zöe PowisDepartment of Clinical Affairs, Ambry Genetics, Aliso Viejo, CA 92656, USA.
Anna ChasseventDepartment of Neurology, Division of Neurogenetics Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Constance Smith-HicksDepartment of Neurology, Division of Neurogenetics Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Slavé PetrovskiCentre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, CB4 0WG, UK; Department of Medicine, the University of Melbourne, Melbourne, VIC 3010, Australia.
Thalia AntoniadiWest Midlands Regional Genetics Laboratory, Birmingham Women's and Children's National Health Service Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2TG, UK.
Vandana ShashiDepartment of Pediatrics, Division of Medical Genetics, Duke University Medical Center, Durham, NC 27710, USA.
Bruce D GelbMindich Child Health and Development Institute, Department of Pediatrics, and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Stephen W WilsonDepartment of Cell and Developmental Biology, Biosciences, University College London, Gower St, London WC1E 6BT, UK.
Dianne GerrelliGreat Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Marco TartagliaGenetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, Scientific Institute for Research, Hospitalization, and Healthcare, 00146 Rome, Italy.
Nicolas ChassaingUDEAR, Université de Toulouse, UMRS 1056 Institut National de la Santé et de la Recherche Médicale-Université Paul Sabatier, 31059 Toulouse, France; Department of Medical Genetics, Purpan University Hospital, 31059 Toulouse, France.
Patrick CalvasUDEAR, Université de Toulouse, UMRS 1056 Institut National de la Santé et de la Recherche Médicale-Université Paul Sabatier, 31059 Toulouse, France; Department of Medical Genetics, Purpan University Hospital, 31059 Toulouse, France.
Nicola K RaggeFaculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, UK; West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's National Health Service Foundation Trust, Birmingham, B15 2TG, UK. Electronic address: nragge@brookes.ac.uk.
University College London · GBBambino Gesù Children's Hospital · ITNational Health Service · GBOdense University Hospital · DKOxford Brookes University · GBDuke Medical Center · USKennedy Krieger Institute · USUniversité Fédérale de Toulouse Midi-Pyrénées · FRUniversity Medical Center Utrecht · NLAmbry Genetics (United States) · USAstraZeneca (United Kingdom) · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBCasa Sollievo della Sofferenza · ITChild Health and Development Institute · USDuke University · USUniversité Toulouse III - Paul Sabatier · FRUniversity of California, San Francisco · USUniversity of Washington · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
Pediatric Heart Disease: Getting from Mutations to TherapeuticsR35HL135742 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GELB, BRUCE D · 2017 to 2023
$6.1M
Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
Medical Research Council MR/L003775/1Medical Research Council MR/R006237/1NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R35 HL135742NIH HHS S10 OD018522NINDS NIH HHS R01 NS058721Wellcome TrustWellcome Trust 104682/Z/14/Z
6 · The paper itself

Abstract

The identification of genetic variants implicated in human developmental disorders has been revolutionized by second-generation sequencing combined with international pooling of cases. Here, we describe seven individuals who have diverse yet overlapping developmental anomalies, and who all have de novo missense FBXW11 variants identified by whole exome or whole genome sequencing and not reported in the gnomAD database. Their phenotypes include striking neurodevelopmental, digital, jaw, and eye anomalies, and in one individual, features resembling Noonan syndrome, a condition caused by dysregulated RAS signaling. FBXW11 encodes an F-box protein, part of the Skp1-cullin-F-box (SCF) ubiquitin ligase complex, involved in ubiquitination and proteasomal degradation and thus fundamental to many protein regulatory processes. FBXW11 targets include β-catenin and GLI transcription factors, key mediators of Wnt and Hh signaling, respectively, critical to digital, neurological, and eye development. Structural analyses indicate affected residues cluster at the surface of the loops of the substrate-binding domain of FBXW11, and the variants are predicted to destabilize the protein and/or its interactions. In situ hybridization studies on human and zebrafish embryonic tissues demonstrate FBXW11 is expressed in the developing eye, brain, mandibular processes, and limb buds or pectoral fins. Knockdown of the zebrafish FBXW11 orthologs fbxw11a and fbxw11b resulted in embryos with smaller, misshapen, and underdeveloped eyes and abnormal jaw and pectoral fin development. Our findings support the role of FBXW11 in multiple developmental processes, including those involving the brain, eye, digits, and jaw.

Indexed as

Mutation, MissensePhenotypeAdolescentAdultbeta-Transducin Repeat-Containing ProteinsBrainChildChild, PreschoolEye AbnormalitiesFemaleFingersHumansMaleUbiquitin-Protein Ligasesbeta-Transducin Repeat-Containing ProteinsFBXW11 protein, humanUbiquitin-Protein LigasesbraindevelopmentdigiteyeFBXW11hedgehogneurodevelopmentNoonan syndromeWD40Wnt

Identifiers

PMID31402090
PMCPMC6731360
OpenAlexW2965149872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.